Vaginal DNA Assay Shows Promise - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

  • By

  • Kerri Miller

  • May 8, 2026

  • 14 min

Share

Original Source(s)

Vaginal DNA Assay Shows Promise

  • by Kerri Miller

  • May 8, 2026

Related Content

Anti-CGRP antibodies may raise miscarriage risk

Findings from 7,579 pregnancies suggest a potential safety concern with migraine prevention during early pregnancy.

Is the reported benefit of the Endo-App truly sustained?

Point-of-care ultrasound in obstetrics and gynecology: latest advancements and evolution